bpc-157 double strength Peptide: & TB-500 in The Colony TX BPC-157 – Mark Hyman, MD

Karlijn de Laat: Nothing to disclose

It was not identified by name in the reviewed WADA list, but the S0 category broadly covers non-approved pharmacological substances

We introduced a series of seminars for patients and healthcare professionals raising awareness about diagnosis and treatment of PA including important topics like iron deficiency We updated our website and information sheets We explored and continue to work on research projects for those issues identified in the NICE recommendations on B12 deficiency and in the James Lind Alliance Priority Setting Partnership

For broader care, explore mobile IV therapy services or contact purelyIV if you want help choosing a starting point